Fuse Oncology develops a practice management platform that utilizes artificial intelligence to streamline clinical documentation and unify fragmented data in radiation oncology. This technology reduces administrative workload, enhances decision-making, and accelerates patient care pathways, ultimately improving operational efficiency for oncology practices.
Funding
$8.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Radiation oncology practices face challenges with fragmented data, manual clinical documentation, and potential errors in coding and billing processes. These inefficiencies can lead to increased administrative workloads, delayed care pathways, and revenue loss.
Solution
Fuse Oncology offers an AI-powered software suite designed to streamline clinical workflows and unify data within radiation oncology practices. The platform automates tasks such as clinical documentation, coding, and charge capture, reducing the burden on clinicians and administrative staff. By leveraging AI, Fuse Oncology identifies and resolves errors, accelerates patient care pathways, and improves operational efficiency. The integrated solutions aim to improve revenue cycle management, reduce workload, and allow clinicians to focus more on patient care.
Target Audience
The primary target audience includes radiation oncology practices, hospitals, and healthcare systems seeking to improve efficiency, reduce errors, and enhance revenue cycle management.
Features
- AI-driven automation of clinical documentation and coding processes
- Real-time error detection and resolution to prevent charge capture errors
- Unified data platform for streamlined access to patient information
- Integration with existing radiation oncology systems
- Customizable dashboards for monitoring key performance indicators
- Automated charge capture reconciliation
- Tools for managing equipment and resources